most dramatic results have been observed in the patient with diabetes, when judicious application of MDT to early gangrene, say of a digit, can check the process and avoid the major surgery that otherwise would inevitably be necessary in many cases. The implicit value of these observations remains to be exploited. Imagine a patient with impending critical limb ischemia and gangrene who may be unfit for surgery or unwilling to have it. In such a case, MDT could be most helpful by reducing necrotic tissue and thereby the levels of toxins circulating in the patient. Widespread use of MDT could have immense value not only in helping patients but also in terms of saving bed occupancy and therefore costs.
This therapy may not be advised for some patients with arterial disease and chronic painful ulcers, mainly because in such wounds the maggot activity may itself increase pain levels. However, MDT appears to be a safe treatment, with no major or life-threatening complications yet reported. It is demanding, though, in that the practitioner must have a good understanding of the natural biology of these living organisms and thus manage them to obtain the best clinical results in a varied and changing wound environment. The knowledge base is available; using it to maximum advantage is our responsibility. 2 
